SENS-401
Drug timelines are a Plus or Pro feature.
4 regulatory and trial events tracked for SENS-401, covering 2023-03-01 to 2026-07-02. Get the full timeline:
Most recent: Clinical Trial Results: SENS-401 to Prevent the Ototoxicity Induced by Cisplatin in Adult Subjects With a Neoplastic Disease [Phase 2]